acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
import
caus
morbid
mortal
unit
state
estim
incid
ali
case
per
year
inhospit
mortal
rate
nearli
littl
known
incid
viral
infect
adult
ali
studi
children
itali
communityacquir
pneumonia
without
specif
ali
found
enrol
children
viral
infect
direct
fluoresc
antigen
dfa
polymeras
chain
reaction
pcr
clinic
practic
viral
infect
diagnos
use
dfa
assay
pcrbase
assay
viral
cultur
method
assess
wellknown
human
pathogen
includ
influenza
b
parainfluenza
respiratori
syncyti
viru
rsv
adenoviru
metapneumoviru
rhinoviru
enteroviru
coronaviru
cytomegaloviru
cmv
research
laboratori
abil
detect
mani
virus
nucleic
acid
amplif
method
although
clinic
signific
virus
well
understood
review
focus
two
virus
caus
major
respiratori
ill
epidem
keyword
acut
respiratori
distress
syndrom
ard
angiotensinconvert
enzym
pulmonari
edema
alveolar
epithelium
lung
endothelium
abstract
acut
viral
pneumonia
import
caus
acut
lung
injuri
ali
although
enough
known
exact
incid
viral
infect
ali
polymeras
chain
reactionbas
assay
direct
fluoresc
antigen
dfa
assay
viral
cultur
detect
virus
sampl
human
respiratori
tract
presenc
viru
prove
pathogen
give
inform
regard
interact
virus
host
immun
respons
bacteri
flora
respiratori
tract
sever
acut
respiratori
syndrom
sar
epidem
influenza
pandem
provid
better
understand
viral
pathogen
mediat
lung
injuri
although
virus
initi
infect
respiratori
epithelium
rel
role
epitheli
damag
endotheli
dysfunct
well
defin
inflammatori
host
immun
respons
infect
major
contributor
lung
injuri
sar
coronaviru
caus
lung
injuri
inflamm
part
action
nonclass
renin
angiotensin
pathway
lesson
learn
pandem
outbreak
sar
coronaviru
captur
key
principl
viral
mediat
ali
pathogenspecif
pathway
underli
viral
mediat
ali
converg
onto
common
end
pathway
result
diffus
alveolar
damag
term
therapi
lung
protect
ventil
cornerston
support
care
littl
evid
corticosteroid
benefici
might
harm
futur
therapeut
strategi
may
target
specif
pathogen
pathogenet
pathway
host
immun
respons
enhanc
repair
regener
tissu
damag
last
decad
sever
acut
respiratori
syndrom
coronaviru
sar
cov
pandem
influenza
viru
year
follow
outbreak
research
use
anim
model
elucid
mechan
involv
viral
mediat
ali
investig
common
viral
pathogen
also
reshap
way
think
role
viral
infect
ali
exampl
cmv
common
pathogen
sever
immunosuppress
popul
especi
organ
transplant
recipi
previous
thought
uncommon
pathogen
nosocomi
pneumonia
new
diagnost
tool
import
detect
prevent
treatment
cmv
pneumonia
broader
popul
critic
ill
patient
reconsid
seropreval
cmv
adult
rang
cmv
detect
nonimmunocompromis
adult
critic
ill
thought
reactiv
latent
infect
associ
longer
intens
care
unit
icu
hospit
stay
longer
durat
mechan
ventil
increas
rate
nosocomi
infect
cmv
infect
associ
increas
interleukin
il
vitro
vivo
cytokin
associ
ali
ard
autopsi
studi
suggest
cmv
may
import
pathogen
ventilatorassoci
pneumonia
vap
observ
provid
rational
prospect
random
trial
cmv
prevent
antivir
agent
ganciclovir
novel
mean
improv
outcom
critic
ill
patient
era
sensit
rapid
nucleic
acid
amplif
diagnost
test
detect
presenc
infecti
agent
determin
particular
virus
pathogen
interact
host
immun
system
caus
lung
injuri
resolut
infect
area
activ
research
import
gain
better
understand
molecular
pathophysiolog
communityacquir
nosocomi
viral
pneumonia
devis
target
therapi
current
treatment
larg
support
underli
pathophysiolog
viral
mediat
ali
well
understood
like
uniqu
signatur
mechan
viral
strain
converg
onto
common
end
pathway
result
diffus
alveolar
damag
dad
remain
seen
whether
epitheli
injuri
primari
lesion
coincid
endotheli
injuri
communityacquir
respiratori
viral
pneumonia
inhal
bind
receptor
upper
respiratori
tract
although
virus
initi
infect
respiratori
epithelium
possibl
mere
portal
entri
import
step
alveolar
damag
mediat
primarili
endotheli
injuri
result
elabor
cytokin
chemokin
recruit
innat
adapt
immun
cell
specif
cytokin
profil
vari
viral
pathogen
may
driven
macrophag
epitheli
cell
endotheli
cell
combin
crosstalk
lung
injuri
primarili
mediat
viral
infect
rather
result
inflammatori
host
respons
viral
clearanc
may
central
resolut
lung
injuri
lesson
learn
studi
pandem
outbreak
sar
cov
infect
review
articl
februari
outbreak
sar
first
report
guangdong
provinc
china
patient
present
fever
lower
respiratori
tract
symptom
infiltr
chest
radiographi
consist
pneumonia
ard
within
month
case
report
hong
kong
singapor
vietnam
canada
world
health
organ
launch
effort
investig
ill
contain
rapid
spread
index
case
physician
guandong
provinc
travel
hong
kong
day
symptom
onset
ill
rapidli
spread
two
dozen
countri
north
america
south
america
europ
asia
sar
global
outbreak
contain
http
wwwwhointcsrsarsen
april
caus
agent
identifi
new
member
order
nidoviral
coronaviru
famili
coronavirida
sar
cov
envelop
rna
viru
replic
transcript
discontinu
nest
messeng
rna
mrna
reservoir
viru
thought
civet
cat
nocturn
mammal
consid
delicaci
southern
china
horsesho
bat
may
also
reservoir
incub
period
day
symptom
onset
peak
viral
shed
respiratori
secret
occur
rel
late
day
viru
spread
respiratori
secret
shed
via
contact
fomit
airborn
transmiss
particularli
intern
flight
contribut
superspread
outbreak
phenomenon
juli
case
report
death
due
sar
cov
yield
case
fatal
rate
juli
lift
travel
advisori
outbreak
sar
end
later
four
small
sar
outbreak
three
laboratorybas
outbreak
one
attribut
exposur
infect
palm
civet
sever
epidemiolog
studi
use
logist
regress
show
older
age
underli
comorbid
condit
diabet
chronic
obstruct
pulmonari
diseas
hepat
b
infect
cancer
cardiac
diseas
associ
wors
outcom
includ
icu
admiss
mechan
ventil
death
estim
case
fatal
rate
patient
younger
year
patient
age
year
older
assum
parametr
gamma
distribut
characterist
patient
suscept
infect
fairli
nonspecif
provid
limit
insight
mechan
ali
mediat
sar
cov
infect
specul
sever
infect
older
individu
relat
oxidativestress
machineri
increas
innat
immun
respons
robust
inflammatori
respons
older
individu
age
macaqu
stronger
host
respons
viral
infect
show
increas
differenti
express
gene
associ
inflamm
specif
nuclear
factor
kappa
b
nfkb
express
upregul
type
interferon
ifn
downregul
older
macaqu
associ
sever
lung
injuri
clinic
patholog
patient
die
sar
infect
easili
distinguish
sarsmedi
ali
seminar
respiratori
critic
care
medicin
vol
viral
pathogen
ali
hendrickson
matthay
type
lung
injuri
ard
earli
report
sar
case
fatal
nan
fang
hospit
guangdong
china
show
pulmonari
lesion
includ
dad
hyalin
membran
format
local
hemorrhag
necrosi
desquam
pulmonari
alveol
bronchiti
prolifer
desquam
alveolar
epitheli
cell
exud
protein
monocyt
lymphocyt
plasma
cell
alveoli
hyalin
membran
format
viral
inclus
bodi
alveolar
epitheli
cell
also
observ
electron
microscopi
demonstr
cluster
viral
particl
consist
cov
lung
tissu
case
control
seri
univers
toronto
describ
postmortem
studi
patholog
specimen
patient
die
march
juli
sar
confirm
revers
transcript
rt
pcr
author
compar
patient
ageand
gendermatch
sar
covneg
patient
present
lower
respiratori
tract
sign
symptom
die
time
period
sar
patient
longer
mean
durat
ill
control
like
evid
organ
pneumonia
hematoxylin
eosinstain
slide
sar
case
exhibit
patholog
evid
dad
wherea
control
evid
dad
author
report
signific
overlap
sar
nonsar
case
patient
die
ard
note
difficult
imposs
differenti
alveolar
damag
sar
infect
etiolog
overal
find
suggest
mechan
ali
initi
sar
cov
infect
common
pathway
mechan
result
dad
organ
pneumonia
outbreak
sar
infect
brief
thank
effect
contain
effort
orchestr
center
diseas
control
prevent
cdc
cooper
govern
affect
countri
shortliv
outbreak
sar
cov
infect
provid
littl
time
studi
effect
therapi
case
ali
treatment
sar
larg
support
known
effect
target
therapi
clear
role
corticosteroid
limit
vitro
clinic
trial
data
ard
studi
exist
treatment
ribavirin
corticosteroid
lopinavir
ritonavir
lpvr
type
ifn
intraven
immunoglobulin
ivig
sar
convalesc
plasma
systemat
review
literatur
sponsor
report
sar
cov
infect
tissu
cultur
model
inhibit
ribavirin
lopinavir
type
ifn
howev
sarsinfect
patient
report
ribavirin
studi
inconclus
four
show
possibl
harm
seven
studi
convalesc
plasma
ivig
three
ifn
type
two
lpvr
inconclus
studi
steroid
use
inconclus
classifi
caus
possibl
harm
case
sar
report
sinc
although
best
care
strategi
infect
individu
still
unclear
viru
provid
opportun
studi
pathway
involv
ali
may
common
lung
injuri
mediat
infecti
agent
system
ill
membranebound
spike
glycoprotein
critic
receptor
bind
membran
fusion
viru
host
cell
li
et
al
publish
data
immunoprecipit
experi
mass
spectroscopi
identifi
novel
protein
angiotensinconvert
enzym
bind
target
spike
protein
sar
cov
viru
integr
membran
metallopeptidas
cleav
angiotensin
ii
atii
form
angiotensin
ang
bind
sar
cov
receptor
caus
intern
viru
downregul
express
discoveri
led
extens
investig
role
anim
ali
model
tissu
tropism
sar
cov
correl
express
includ
lung
gastrointestin
tract
kidney
liver
human
protein
detect
throughout
respiratori
tree
includ
epitheli
cell
alveoli
trachea
bronchi
bronchial
serou
gland
well
pneumocyt
alveolar
monocyt
macrophag
express
alveolar
epithelium
type
type
ii
alveolar
epitheli
cell
vascular
endothelium
lung
human
seem
initi
bind
viru
respiratori
tract
progress
sever
ill
lung
injuri
involv
endotheli
patholog
well
although
ctype
lectin
also
known
lsign
dendrit
cellspecif
ctype
lectin
bind
sar
cov
appear
key
function
receptor
viru
play
central
role
nonclass
renin
angiotensin
system
ra
activ
classic
nonclass
ra
pathway
appear
balanc
normal
physiolog
condit
howev
sever
ali
model
activ
ii
ace
increas
signal
angiotensin
ia
receptor
activ
downregul
neg
regul
ace
pathway
cleav
ii
form
ang
downstream
effect
ang
kidney
mediat
g
proteincoupl
receptor
ma
appear
antagonist
necessari
sar
cov
viru
infect
alveolar
epitheli
cell
mice
sar
covinfect
cell
express
proinflammatori
cytokin
includ
transform
growth
factor
tgf
monocyt
chemotact
protein
data
suggest
lack
type
ifn
respons
may
import
sar
covmedi
lung
injuri
administr
type
ifn
age
macaqu
infect
sar
cov
reduc
lung
injuri
varieti
ali
anim
model
suggest
increas
signal
ace
downstream
cytokin
decreas
signal
may
import
lung
injuri
imai
et
al
publish
find
seri
murin
knockout
rescu
experi
show
ii
upregul
ace
drive
ali
angiotensin
ii
receptor
protect
lung
injuri
aspir
sepsi
model
author
show
loss
express
precipit
sever
acut
lung
failur
three
separ
ali
model
lung
injuri
knockout
mice
result
increas
elast
worsen
hypoxemia
compar
wildtyp
mice
subject
acid
aspir
lung
injuri
knockout
lung
injuri
phenotyp
rescu
intraperiton
administr
recombin
human
protein
ace
knockout
protect
lung
injuri
gene
dosedepend
fashion
heterozygot
show
intermedi
reduct
lung
complianc
acidinduc
lung
injuri
compar
wildtyp
ace
knockout
ace
knockout
rescu
knockout
lung
injuri
gene
dosedepend
fashion
result
improv
lung
complianc
reduct
pulmonari
edema
seen
knockout
mice
acid
aspir
lung
injuri
receptor
blockad
rescu
knockout
lung
injuri
antagonist
amelior
lung
injuri
wildtyp
mice
acid
aspir
lung
injuri
similar
result
report
bleomycininduc
lung
injuri
model
knockout
worsen
bleomycininduc
lung
injuri
find
forego
seri
knockout
rescu
experi
show
increas
ace
activ
mediat
ali
activ
protect
investig
infer
therapeut
strategi
inhibit
ra
would
mitig
downstream
elabor
inflammatori
cytokin
amelior
lung
injuri
prospect
studi
lipopolysaccharid
lp
mediat
lung
injuri
model
rat
show
pretreat
enalapril
ace
inhibitor
inhibit
ace
activ
increas
serum
activ
reduc
serum
express
proinflammatori
cytokin
reduc
lung
injuri
lp
pretreat
enalapril
suppress
nuclear
factor
kappa
b
downstream
target
ii
rat
subject
lpsmediat
lung
injuri
rat
subject
lpsinduc
lung
injuri
moder
tidal
volum
mechan
ventil
oxygen
improv
anim
treat
losartan
angiotensin
receptor
blocker
administr
cyclic
ang
also
significantli
improv
oxygen
anim
model
lung
injuri
although
earlier
studi
focus
serum
level
ace
asperen
et
al
show
bronchoalveolar
lavag
bal
fluid
rat
lpsand
mechan
ventilationinduc
ard
ace
activ
higher
activ
lower
spontan
breath
anim
similarli
ii
level
higher
ang
fig
schemat
represent
sever
acut
respiratori
syndrom
coronaviru
sar
cov
infect
mediat
acut
lung
injuri
angiotensinconvert
enzym
ace
angiotensinconvert
enzym
signal
pathway
ace
convert
angiotensin
angiotensin
ii
ii
ii
bind
angiotensin
ii
receptor
lead
tissu
damag
lung
edema
bind
angiotensin
ii
receptor
reduc
tissu
damag
inactiv
ii
gener
angiotensin
sar
cov
bind
caus
downregul
intern
membranebound
protein
lead
viral
replic
cytoplasm
illustr
viru
infect
type
ii
pneumocyt
administr
recombin
reduc
lung
damag
inactiv
ii
level
lower
anim
ard
spontan
breath
anim
although
statist
signific
total
protein
bal
specimen
anim
lpsinduc
lung
injuri
treat
either
losartan
cyclic
ang
tend
lower
find
suggest
treatment
aim
blunt
ace
signal
pathway
activ
enhanc
signal
pathway
may
reduc
inflamm
lung
injuri
amount
protein
accumul
alveoli
treml
et
al
conduct
prospect
random
doubleblind
studi
recombin
human
treatment
piglet
lpsinduc
ard
anim
intub
mechan
ventil
pulmonari
arteri
cathet
place
prior
lpsinduc
lung
injuri
small
studi
six
piglet
receiv
sham
normal
salin
infus
six
anim
receiv
infus
recombin
anoth
three
anim
serv
neg
control
receiv
lp
therapi
piglet
treat
recombin
higher
partial
pao
reduct
mean
pulmonari
arteri
pressur
unchang
wedg
pressur
author
use
inert
ga
elimin
evalu
ventil
perfus
match
found
pulmonari
blood
flow
homogen
anim
treat
author
address
concern
lower
system
blood
pressur
agent
inhibit
ra
cleav
ii
control
anim
expos
lp
treatment
induc
hypotens
ii
level
undetect
anim
anim
lpsinduc
lung
injuri
found
eightfold
elev
ii
treatment
result
ii
level
basal
level
chang
blood
pressur
significantli
cytokin
profil
reflect
downstream
signal
effect
disrupt
ace
balanc
examin
lung
sampl
obtain
postmortem
sar
victim
african
green
monkey
macaqu
mice
quantit
pcr
analysi
postmortem
sampl
sar
victim
show
varieti
gene
upregul
includ
situ
hybrid
studi
postmortem
lung
specimen
use
monoclon
antibodi
show
elabor
variou
proinflammatori
cytokin
sar
covinfect
cell
tgf
tumor
cardiotrophinlik
cytokin
upregul
lung
organ
sar
patient
african
green
monkey
develop
sever
lung
injuri
macaqu
sar
cov
infect
induc
upregul
african
green
monkey
find
suggest
differenti
express
proinflammatori
gene
may
critic
pathogenesi
sever
lung
injuri
induc
sar
cov
infect
summari
downstream
signal
pathway
activ
sar
cov
infect
mediat
ace
activ
well
understood
appear
reflect
nonspecif
elabor
proinflammatori
cytokin
beyond
postmortem
studi
gross
patholog
gene
express
studi
tissu
sampl
sar
victim
littl
known
pathway
ali
kharofa
et
al
publish
result
small
retrospect
studi
patient
stage
iii
small
cell
nonsmal
cell
lung
cancer
receiv
radiat
therapi
within
veteran
affair
health
care
system
author
found
rate
grade
pneumon
significantli
lower
patient
take
ace
inhibitor
nonus
patient
selfreport
ace
inhibitor
use
similar
use
class
medic
respect
type
stage
cancer
radiat
dosag
lung
volum
irradi
age
concurr
chemotherapi
small
retrospect
cohort
studi
suggest
exposur
ace
inhibitor
may
reduc
risk
radiat
pneumon
postmortem
patholog
studi
variou
vitro
vivo
model
system
sar
cov
infect
suggest
viru
enter
respiratori
tract
bind
alveolar
epithelium
infect
follow
serolog
evid
increas
ace
activ
decreas
activ
signal
pathway
activ
bind
sar
cov
subsequ
downstream
cytokin
elabor
appear
share
common
featur
mechan
ali
result
patholog
phenotyp
indistinguish
mechan
lung
injuri
anim
model
ali
rescu
administr
intraven
intraperiton
agent
restor
balanc
ace
activ
suggest
vascular
endothelium
also
involv
lung
injuri
therapi
may
deliv
system
rather
alveolar
epithelium
site
initi
viral
bind
infect
epidemiolog
featur
person
high
risk
sever
infect
complic
suggest
particular
host
defect
propos
older
individu
may
elabor
robust
inflammatori
respons
due
alter
oxidativestress
machineri
come
age
howev
system
corticosteroid
administ
blunt
downstream
inflammatori
cytokin
elabor
effect
treatment
patient
sar
cov
infect
import
downstream
target
upregul
ace
downregul
yet
well
understood
rel
contribut
endotheli
epitheli
process
develop
lung
injuri
molecular
pathway
link
initi
bind
viru
alveolar
cell
develop
dad
activ
investig
pathway
involv
lung
injuri
induc
sar
cov
infect
may
common
mechan
injuri
includ
lp
acid
aspir
cecal
ligat
perfor
therefor
may
provid
framework
develop
univers
therapi
lung
injuri
mediat
infecti
noninfecti
process
virus
subdivid
base
antigen
character
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
ha
subtyp
nine
na
subtyp
influenza
acut
respiratori
diseas
present
sudden
onset
high
fever
chill
myalgia
upper
respiratori
tract
symptom
diarrhea
infect
rare
induc
symptom
lower
respiratori
tract
infect
sever
lung
injuri
influenza
viru
infect
global
health
concern
sinc
spanish
flu
pandem
three
influenza
pandem
occur
centuri
pandem
caus
differ
antigen
subtyp
influenza
respect
march
novel
influenza
viru
emerg
mexico
unit
state
quickli
spread
worldwid
pandem
viru
origin
triplereassort
swine
influenza
viru
circul
north
american
pig
june
declar
world
pandem
alert
august
almost
everi
countri
report
laboratoryconfirm
case
death
http
html
studi
case
earli
outbreak
unit
state
found
common
present
symptom
fever
cough
sore
throat
patient
diarrhea
vomit
hospit
mortal
data
known
case
show
hospit
rate
case
fatal
ratio
studi
confirm
case
ontario
canada
show
similar
present
symptom
hospit
rate
case
fatal
ratio
pandem
viru
develop
reassort
among
sever
influenza
strain
nucleic
acid
sequenc
show
ha
nucleoprotein
np
nonstructur
protein
ns
gene
segment
classic
swine
virus
gene
segment
human
season
influenza
virus
pa
gene
avian
influenza
virus
na
gene
segment
genet
differ
previous
isol
human
pathogen
found
origin
eurasian
swine
influenza
strain
studi
ferret
mice
show
compar
season
intranas
inocul
pandem
caus
higher
morbid
higher
viral
titer
lung
tissu
viral
shed
gastrointestin
tract
suggest
invas
pathogen
season
influenza
caus
highest
mortal
rate
among
older
person
contrast
pandem
affect
young
individu
disproportion
major
patient
children
adult
age
year
recov
unev
overal
mortal
higher
season
influenza
risk
factor
sever
infect
pandem
includ
extrem
age
underli
medic
ill
obes
pregnanc
howev
previous
healthi
patient
without
comorbid
develop
rapidli
progress
pneumonia
ard
multiorgan
failur
death
ard
report
promin
caus
death
patient
sever
diseas
present
fever
cough
respiratori
distress
bilater
patchi
pneumonia
elev
serum
lactat
dehydrogenas
ldh
creatinin
kinas
level
leukopenia
featur
common
cohort
adult
children
studi
worldwid
find
sever
epidemiolog
studi
suggest
pregnant
women
obes
individu
suscept
sever
infect
pandem
molecular
mechan
underpin
associ
clear
relationship
obes
inflammatori
cascad
respons
ali
variou
mechan
area
activ
research
adipocyt
macrophag
isol
obes
patient
secret
larg
quantiti
proinflammatori
cytokin
includ
releas
factor
serum
shown
contribut
develop
obesityrel
metabol
cardiovascular
diseas
hypothes
chronic
inflamm
may
also
prime
lung
tissu
ali
proinflammatori
properti
lectin
antiinflammatori
properti
adiponectin
may
also
influenc
risk
develop
ali
although
epidemiolog
data
pandem
suggest
obes
patient
higher
risk
ali
elev
level
variou
inflammatori
cytokin
cytokin
profil
sera
collect
ardsnet
particip
show
obes
patient
ali
induc
varieti
mechan
lower
level
proinflammatori
cytokin
find
suggest
descript
serum
cytokin
profil
vari
diseas
state
unlik
cytokin
profil
conserv
among
mechan
ali
viral
infect
interestingli
aforement
studi
find
elev
level
surfact
protein
spd
von
willebrand
factor
vwf
marker
endotheli
injuri
obes
patient
ali
epitheli
injuri
may
less
import
endotheli
disrupt
mechan
ali
recent
studi
obes
mice
show
obes
associ
neutrophil
dysfunct
attenu
murin
ali
lp
model
studi
specif
investig
role
endotheli
compart
murin
ali
treatment
infect
gener
support
patient
infect
viru
experi
typic
influenza
symptom
fulli
recov
within
week
requir
antivir
therapi
patient
sever
ill
lower
respiratori
symptom
treat
na
inhibitor
oseltamivir
case
nebul
zanamivir
intraven
peramivir
oseltamivir
avail
case
sever
ill
higher
dose
oseltamivir
longer
durat
treatment
may
consid
although
author
prospect
case
seri
patient
bueno
air
ard
ali
present
flulik
ill
suggest
treatment
corticosteroid
addit
na
inhibitor
safe
recommend
treatment
strategi
sever
infect
eight
patient
pcrconfirm
small
size
studi
limit
analysi
mortal
differ
convinc
data
suggest
use
system
corticosteroid
treat
sever
infect
benefici
corticosteroid
use
associ
poor
outcom
viral
respiratori
diseas
earli
use
corticosteroid
sar
influenza
associ
prolong
period
viral
replic
may
increas
rate
secondari
bacteri
vap
recommend
respiratori
support
patient
ard
ali
similar
wide
accept
use
lungprotect
ventil
lower
tidal
volum
fluid
conserv
strategi
advanc
support
measur
refractori
hypoxemia
extracorpor
membran
oxygen
ecmo
highfrequ
oscil
ventil
prone
posit
neuromuscular
blockad
inhal
nitric
oxid
effect
icu
expertis
modal
ivig
nacetyllcystein
use
treat
infect
influenza
subtyp
use
studi
infect
mechan
ali
infect
well
understood
treatment
patient
infect
pandem
influenza
larg
support
unravel
molecular
underpin
viral
replic
host
immun
respons
infect
may
lead
target
therapi
immunomodulatori
strategi
could
broadli
appli
mechan
ali
experi
anim
model
ad
inform
cytokin
cascad
inflammatori
respons
infect
although
extrapol
data
human
infect
challeng
mani
compet
anim
model
suggest
could
signific
differ
speci
furthermor
mani
differ
strain
use
experiment
model
strain
subject
fairli
rapid
rate
mutat
epidemiolog
studi
summar
follow
provid
littl
inform
patient
develop
sever
ill
character
inflammatori
respons
viral
infect
lead
ali
sever
case
show
nonspecif
patholog
find
dad
without
hemorrhag
necrot
bronchiol
relationship
epitheli
endotheli
injuri
well
understood
experiment
model
alway
distinguish
direct
cytotox
effect
alveolar
epitheli
cell
infect
host
inflammatori
respons
aris
endotheli
injuri
system
circul
factor
small
minor
patient
infect
pandem
go
develop
seriou
ill
necessit
hospit
intens
care
factor
mitig
sever
inflammatori
host
respons
still
unclear
studi
sera
patient
hong
kong
infect
show
thelper
thelper
hypercytokinemia
earli
host
respons
sever
case
prospect
analysi
cytokin
chemokin
profil
sera
patient
spain
infect
show
common
express
pattern
innat
antivir
respons
protein
across
patient
mild
ill
sever
present
subject
infect
show
increas
express
chemokin
chemokin
also
upregul
sar
cov
rsv
infect
marker
innat
immun
respons
viral
infect
author
compar
serum
cytokin
profil
infect
outpati
patient
noncrit
respiratori
insuffici
admit
hospit
critic
ill
patient
respiratori
insuffici
patient
respiratori
compromis
increas
level
cytokin
compar
healthi
individu
outpati
control
critic
ill
patient
elev
serum
level
proinflammatori
cytokin
stimul
adapt
immun
respons
may
repres
patholog
differ
host
respons
infect
caus
mild
ill
result
sever
system
inflammatori
respons
studi
patient
romania
ard
mild
diseas
show
sever
influenza
viru
infect
character
cytokin
except
posit
correl
admiss
delay
creactiv
protein
neg
correl
pao
fio
ratio
note
studi
level
elev
patient
sever
diseas
interestingli
obes
patient
pandem
infect
significantli
higher
level
infect
nonobes
patient
find
differ
previous
describ
result
stapleton
et
al
use
sera
ardsnet
patient
collect
pandem
three
distinct
pulmonari
histolog
pattern
describ
autopsi
studi
patient
infect
pandem
dad
necrot
bronchiol
dad
intens
pulmonari
hemorrhag
sever
case
seri
found
signific
proport
patient
sever
infect
secondari
bacteri
pneumonia
streptococcu
staphylococcu
haemophilu
speci
case
multipl
bacteri
pathogen
isol
autopsi
studi
show
result
nonspecif
final
patholog
pattern
may
predispos
superimpos
bacteri
infect
recent
cohort
studi
rice
et
al
found
bacteri
coinfect
common
patient
infect
pandem
admit
ardsnet
icu
north
america
thirti
percent
patient
studi
evid
bacteri
coinfect
patient
bacteri
infect
staphylococcu
aureu
blood
respiratori
cultur
streptococcu
pneumonia
human
studi
serum
bal
fluid
autopsi
specimen
shed
much
light
molecular
mechan
involv
ali
clinic
respons
influenza
infect
rang
mild
diseas
sever
pneumonia
remain
unclear
whether
inflammatori
respons
infect
protect
pathogen
experi
use
varieti
anim
model
provid
detail
inform
inflammatori
respons
infect
area
investig
potenti
therapeut
strategi
find
anim
model
extrapol
human
diseas
caution
case
pandem
influenza
infect
import
recogn
research
group
use
varieti
anim
model
differ
viral
strain
sever
viral
isol
use
variou
research
group
studi
infect
mous
model
includ
pandem
influenza
apuerto
furthermor
strain
subject
mutat
may
import
implic
data
interpret
sever
research
demonstr
viral
mutat
clinic
experiment
strain
confer
higher
virul
exampl
substitut
glutam
glycin
posit
viral
hemagglutinin
found
significantli
frequent
patient
sever
pandem
influenza
furthermor
mutat
shown
confer
higher
virul
mice
addit
mutat
within
given
strain
subtyp
variat
also
influenc
experiment
find
although
tempt
extrapol
data
viral
subtyp
pandem
infect
approach
mislead
howev
garigliani
et
al
found
two
differ
influenza
viru
subtyp
evok
dad
final
patholog
find
abl
describ
differ
featur
within
dad
pattern
interestingli
mice
infect
virus
show
differ
cours
ard
blind
examin
histopatholog
find
could
distinguish
differ
signatur
featur
find
suggest
although
infect
two
viral
subtyp
ultim
result
nonspecif
find
dad
may
conserv
inflammatori
pathway
underli
sever
influenza
infect
select
appropri
anim
model
accur
reflect
human
immun
respons
infect
develop
lung
injuri
challeng
model
pandem
flu
develop
mice
ferret
guinea
pig
nonhuman
primat
strain
adapt
infect
host
interest
mous
model
gener
bulk
avail
data
infect
crow
et
al
observ
knockout
mice
recruit
fewer
neutrophil
airway
respons
challeng
either
influenza
viru
hydrochlor
acid
decreas
neutrophil
result
lower
amount
oxid
phospholipid
regul
neutrophil
cell
recruit
ligand
furthermor
knockout
mice
lower
morbid
mortal
despit
longer
latenc
viral
clearanc
higher
viral
titer
knockout
mice
less
lung
injuri
indic
less
total
protein
ldh
activ
bal
fluid
less
sever
inflamm
histolog
examin
differ
inflamm
wildtyp
mice
correl
well
differ
mani
inflammatori
cytokin
importantli
three
proinflammatori
cytokin
gener
elev
sever
influenza
infect
part
cytokin
storm
either
trend
lower
significantli
reduc
anim
data
support
potenti
therapeut
manipul
ali
bal
fluid
mice
infect
similar
cytokin
chemokin
profil
human
sera
sampl
studi
patient
spain
hong
kong
describ
earlier
compar
wildtyp
mice
mice
infect
improv
surviv
less
weight
loss
less
leukocyt
infiltr
therefor
lower
lung
injuri
score
decreas
lung
edema
intraven
administ
antibodi
also
reduc
diseas
sever
similarli
crow
et
al
show
mice
reduc
weight
loss
improv
surviv
influenza
infect
data
support
hypothesi
play
critic
role
mediat
lung
injuri
secret
mani
cell
includ
cell
gamma
delta
cell
natur
killer
nk
cell
act
proinflammatori
cytokin
link
innat
adapt
immun
system
recruit
neutrophil
role
varieti
tissu
injuri
model
implic
sever
diseas
process
fulli
human
monoclon
antibodi
develop
novarti
clinic
trial
crohn
diseas
rheumatoid
arthriti
way
follow
intranas
infect
mice
influenza
viru
replic
type
ii
epitheli
cell
line
respiratori
tract
alveolar
macrophag
locat
interfac
air
lung
mediat
innat
immun
respons
elabor
cytokin
respons
limit
replic
influenza
viru
clear
whether
influenza
infect
macrophag
abort
viral
progeni
releas
perhap
limit
releas
virus
infect
mous
macrophag
despit
similar
abil
infect
urin
epitheli
cell
viru
strain
caus
mild
diseas
viru
strain
caus
sever
diseas
infect
murin
airway
macrophag
high
effici
wherea
caus
sever
diseas
macrophagedeplet
mice
caus
sever
diseas
diseas
sever
infect
macrophagedeplet
mice
similar
untreat
mice
express
ha
backbon
amelior
sever
diseas
collect
find
suggest
intern
nonproduct
infect
airway
macrophag
could
critic
factor
limit
sever
diseas
caus
influenza
infect
mice
data
suggest
neutrophil
play
key
role
develop
ali
infect
result
previous
describ
cytokin
elabor
neutrophil
recruit
alveolar
space
sever
mous
model
infect
show
result
similar
epidemiolog
find
pandem
influenza
mutat
ha
mice
infect
develop
ard
mortal
rate
day
infect
mice
show
neutrophilpredomin
infiltr
bal
fluid
serum
elev
infect
mice
ifngamma
alreadi
describ
pregnant
women
higher
risk
develop
sever
infect
pregnant
balbc
mice
higher
mortal
sever
pneumon
higher
pulmonari
viral
load
lower
peripher
blood
lymphocyt
antibodi
respons
higher
level
proinflammatori
cytokin
chemokin
wors
fetal
develop
occur
nonpregn
control
infect
either
wildtyp
clinic
isol
mouseadapt
mutant
viru
substitut
ha
compar
nonpregn
mice
significantli
higher
level
macrophageinflammatori
protein
mip
detect
pregnant
mice
infect
wildtyp
viru
p
wherea
level
elev
significantli
pregnant
mice
infect
mutant
viru
p
notabl
level
significantli
lower
pregnant
mice
nonpregn
mice
p
wherea
level
similar
pregnant
nonpregn
mice
whether
infect
wildtyp
mutant
viru
neutrophil
infiltr
observ
bal
fluid
patholog
specimen
patient
infect
sever
infect
lead
ard
mechan
alveolar
damag
definit
work
neutrophil
primari
role
innat
immun
system
phagocytosi
secret
reactiv
oxygen
intermedi
format
neutrophil
extracellular
trap
net
neutrophil
emit
dna
fiber
carri
nuclear
cytoplasm
protein
trap
extracellular
pathogen
net
attach
capillari
endothelium
associ
vascul
vascular
damag
sepsi
macrophagedeplet
mice
infect
influenza
display
enhanc
viral
replic
excess
neutrophil
infiltr
alveolar
damag
lung
edema
progress
ard
neutrophildeplet
mice
show
mild
lung
patholog
infect
author
note
promin
net
format
lung
tissu
macrophagedeplet
anim
infect
net
also
present
normal
mice
treat
lethal
dose
vitro
studi
suggest
influenza
infect
enhanc
net
format
neutrophil
incub
influenzaprim
alveolar
epitheli
cell
form
net
particular
interact
net
endothelium
could
help
explain
epitheli
endotheli
damag
relat
develop
ard
respons
infect
previous
mention
seem
conserv
patholog
mechan
lung
injuri
induc
differ
influenza
subtyp
murin
model
tate
et
al
show
reduc
number
impair
neutrophil
function
facilit
progress
mild
influenza
sever
clinic
diseas
neutrophil
deplet
monoclon
antibodi
associ
sever
ill
lung
injuri
enhanc
viral
replic
murin
model
infect
endothelium
mani
aforement
studi
specif
distinguish
mechan
injuri
alveolar
epithelium
capillari
endothelium
much
data
base
serum
cytokin
level
alway
correl
alveolar
lavag
sampl
net
provid
one
possibl
explan
inflammatori
respons
compart
may
relat
interestingli
rescu
therapi
murin
model
administ
intraperiton
intraven
effect
system
therapi
deliv
hematogen
alveolu
suggest
endothelium
import
role
cytokin
chemokin
signal
gener
inflammatori
host
respons
sever
influenza
studi
viru
human
microvascular
endotheli
cell
cultur
show
viral
tropism
apic
surfac
high
infect
similar
studi
infect
monolay
cell
cultur
model
human
pulmonari
microvascular
endotheli
cell
show
increas
express
inflammatori
cytokin
interferon
gammainduc
cytokin
express
reduc
inhibit
preb
cell
coloni
enhanc
factor
potenti
biomark
ali
anim
model
receptor
express
endotheli
cell
lymphocyt
within
lung
tissu
mice
receptor
antagonist
suppress
chemokin
cytokin
product
includ
influenza
infect
reduct
cytokin
elabor
associ
decreas
extravas
leukocyt
alveolar
space
decreas
recruit
macrophag
nk
cell
infect
suppress
adapt
immun
respons
associ
improv
mortal
collect
data
suggest
endotheli
cell
orchestr
distinct
event
immun
cell
infiltr
cytokin
product
follow
infect
mice
support
measur
includ
lung
protect
ventil
na
inhibitor
mainstay
therapi
sever
influenza
infect
result
respiratori
failur
ali
monoclon
antibodi
vaccin
direct
conserv
region
influenza
strain
area
ongo
investig
anoth
target
potenti
monoclon
antibodi
therapi
corticosteroid
current
recommend
may
harm
investig
gener
antiinflammatori
therapi
way
exampl
combin
caffein
statin
amelior
lung
injuri
viral
replic
balbc
mice
infect
target
nucleic
acid
therapi
also
studi
fang
et
al
explor
microsatellit
dna
mimick
oligodeoxynucleotid
ms
odn
treatment
infect
day
postinfect
influenza
viru
mice
inject
ms
odn
name
ms
odn
capabl
inhibit
tolllik
receptor
ms
odn
treatment
improv
surviv
less
histopatholog
chang
fewer
neutrophil
per
highpow
field
reduc
level
lung
homogen
investig
therapeut
strategi
import
consid
practic
expect
intervent
document
download
person
use
unauthor
distribut
strictli
prohibit
made
signific
lung
injuri
develop
patient
infect
viral
pneumonia
matter
although
possibl
earlier
identif
patient
requir
posit
pressur
ventil
term
earli
ali
might
facilit
efficaci
futur
therapi
addit
futur
strategi
need
focu
mechan
might
enhanc
repair
use
stem
cell
stem
cellderiv
growth
factor
may
becom
import
therapeut
intervent
patient
ali
ard
independ
mechan
initi
injuri
lesson
learn
studi
pandem
outbreak
sar
cov
captur
key
principl
viral
mediat
ali
appear
sever
pathogenspecif
pathway
underli
viral
mediat
ali
converg
onto
common
end
pathway
result
dad
remain
determin
whether
alveolar
epitheli
injuri
primari
lesion
coincid
lung
endotheli
injuri
also
seem
interact
viral
infect
microbiom
lung
might
predispos
patient
viral
pneumonia
secondari
bacteri
fungal
pneumonia
therapeut
strategi
may
target
specif
pathogen
common
pathway
host
immun
respons
altern
perhap
would
advantag
investig
lung
repair
strategi
reli
less
complet
understand
complic
virushost
interact
repair
final
common
pathway
dad
repair
strategi
may
provid
treatment
viral
mediat
lung
injuri
well
ali
sustain
varieti
insult
scientist
specul
mani
influenza
virus
includ
capabl
caus
pandem
near
futur
loom
threat
next
outbreak
pandem
respiratori
viral
infect
make
compel
argument
continu
investig
host
immun
respons
viral
infect
lung
better
antivir
therapi
research
target
fundament
strategi
enhanc
lung
repair
viral
mediat
ali
